Clinical Trial Update: Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and effectiveness of the Live Zoster Vaccine in patients using anti-TNF therapy for inflammatory diseases, with completed results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Enteropathic Arthritis
• Inflammatory Arthritis
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Live Zoster Vaccine

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Rheumatoid Arthritis, Inflammatory Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-11-23